Myriad Genetics, Inc. (NASDAQ:MYGN) Q3 2024 Earnings Call Transcript November 9, 2024
Operator:
operator: And I would like to turn the call over to Matt Scalo. Please go ahead.
Operator: And I would like to turn the call over to Matt Scalo. Please go ahead.
Matt Scalo: Thank you, Franz, and good afternoon, and welcome to the Myriad Genetics third quarter 2024 earnings call. During the call, we will review financial results we released today. And afterwards, we will host a...
